The Supreme Court directs the Union Government to constitute a committee within two weeks to examine unethical pharmaceutical marketing practices and recommend a suitable statutory and regulatory framework within two months of its first meeting. The Court observes that the existing framework has not proved entirely effective in curbing such practices.
Read Full ArticleThe US has exempted India and 19 other nations from its new 100% Section 232 tariff on patented pharmaceuticals, covering specialty drugs for rare diseases, gene therapies and veterinary medicine. Generic drugs and their ingredients remain entirely outside the tariff's scope.
Piyush Goyal leads a 60-member delegation to Israel to accelerate India–Israel FTA talks, focusing on trade, defence, agriculture, technology and investment.
Granules Life Sciences secures its first U.S. FDA approval for the Hyderabad facility after a successful inspection, marking a major milestone in global expansion.
SC questions if Uniform Code for Pharma Marketing Practices 2024 is truly enforced or just a ‘toothless tiger’, seeks Centre’s response.
The Delhi High Court has ruled in favour of Pharmacyclics LLC and Johnson & Johnson Pvt Ltd (Johnson & Johnson) in a patent infringement suit moved by them for violation of their rights in targeted ca...
The Senior Citizen Rights Handbook is a comprehensive guide designed to empower elderly citizens with clear and accessible knowledge of their legal and social rights in India.
![SC Orders Panel To Review Pharmaceutical Marketing Practices, Seek Recommendations Within Two Months [Read Order]](/secure/uploads/2026/10/lj_4180_Supreme_Court_Scrutiny_of_Pharma_Marketing.webp)
![Pharmacyclics, Johnson & Johnson win patent infringement suit for anti-cancer drug [Read Judgment]](/secure/uploads/2024/01/lj_5765_WhatsApp_Image_2024-01-03_at_5.45.56_PM.jpeg)
